Crinetics Pharmaceuticals, Inc. - Special Call
Crinetics Pharmaceuticals(US:CRNX) Seeking Alphaยท2025-09-26 05:57PresentationI will now turn the call over to Gayathri Diwakar, Head of Investor Relations. Please go ahead.Gayathri DiwakarSenior Director of Investor Relations Thank you, operator. Good afternoon, everyone, and thank you for joining us to discuss the FDA approval of PALSONIFY. Today on the call, we have Dr. Scott Struthers, Founder and Chief Executive Officer; Dr. Dana Pizzuti, Chief Medical and Development Officer; and Isabel Kalofonos, Chief Commercial Officer. In addition, Tobin Schilke, Chief Financial ...